( MENAFN - Straits Research) Introduction High prevalence of anemia, infection, hemophilia, and blood clotting is influencing demand of the market. Bleeding syndromes such as hemophilia & blood clots and blood cancer are some types of blood conditions, increasing demand for fully automated hematology analyzers. Additionally, genetic blood disorder, increasing geriatric population, and rising healthcare sector are propelling the growth of the market.
Furthermore, increasing awereness about the health is also supporting the growth of the market. Market Segmentation The global hematology diagnostic market is segmented into product type, test, end-user, and region. On the basis of product type, the market is segmented into hematology analyzer, flow cytometers, and consumables.
The hematology analyzer if further sub-segmented into fully-automated hematology analyzers and semi-automated hematology analyzers. Whereas, consumable segment is sub-segmented into reagents, stains, controls & calibrators, and others. The hematology analyzer segment is expected to drive the market during the forecast period 2018–2025.
The growing adoption of POC testing, hematology products attached with the rising preference towards automation, the increasing trend of reagent rental business model are some of the factors driving the growth of this segment. Based on the test, the market is segmented into anemia, hemoglobinopathy, leukemia/lymphoma phenotyping, hematology pathophysiology, complete blood c.
